Search

Your search keyword '"Schommers, Philipp"' showing total 305 results

Search Constraints

Start Over You searched for: Author "Schommers, Philipp" Remove constraint Author: "Schommers, Philipp"
305 results on '"Schommers, Philipp"'

Search Results

1. Incidence and risk factors for HIV-tuberculosis coinfection in the Cologne–Bonn region: a retrospective cohort study

3. Dynamics and durability of HIV-1 neutralization are determined by viral replication

5. MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study

7. Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope

10. Human immunodeficiency virus‐associated Lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up.

13. Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections

17. 15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study

20. CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)

22. Immunological fingerprint in coronavirus disease-19 convalescents with and without post-COVID syndrome

24. Immune response to mRNA ‐based COVID ‐19 booster vaccination in people living with HIV

25. A second update on mapping the human genetic architecture of COVID-19

27. SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns

29. A naturally arising broad and potent CD4-binding site antibody with low somatic mutation

30. Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens

31. Probabilities of HIV-1 bNAb development in healthy and chronically infected individuals

32. A naturally arising broad and potent CD4-binding site antibody with low somatic mutation

33. Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens

34. Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers

35. SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns

36. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

37. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

38. Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study

40. CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients

41. Delineating antibody escape from Omicron sublineages

42. Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers

44. CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients

47. Correction to: Treatment modifcation after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017

48. Swarm Learning for decentralized and confidential clinical machine learning

49. Do MYC Alterations Matter in HIV-Associated Large B Cell Lymphomas? the "Euromyc" Study (a European retrospective study)

Catalog

Books, media, physical & digital resources